TNB Tech Minute: Visa Acquires Fraud Reduction Platform in AI Push
August 3, 2026
AI Summary
5 min readVisa is spending $2.4 billion in cash to acquire BioCatch, an Israeli company that uses AI to detect fraud in real time. The deal, expected to close by the end of Visa’s fiscal second quarter of 2027, is the latest sign of how aggressively the payments giant is leaning into artificial intelligence to protect its network.
Visa Buys BioCatch for $2.4 Billion
BioCatch says it protects 1.8 billion devices and 760 million users globally. Its technology distinguishes legitimate users from attackers as transactions happen, which is a core concern for a company like Visa that processes trillions of dollars in payments each year. The acquisition fits into a broader pattern: Visa has spent $13 billion on fraud technology and infrastructure over the past five years. The cash deal signals that Visa sees real-time behavioral analytics as a critical piece of its future, not just an add-on.
AstraZeneca and Bristol-Myers Squibb Merger Talks Reported
Continue reading the full summary in the app — free to try.
Read Full Summary →Free • No credit card required
Never miss an episode of WSJ Tech News Briefing
Get every new episode summarized in your inbox — free, ~5 minutes to read.
No spam. Unsubscribe anytime.
What you'll learn
- 1 (00:36) **Episode Introduction** - Host Imani Melieze opens the TNB Tech Minute for Monday, August 3rd.
- 2 (00:43) **Visa Acquires BioCatch for $2.4 Billion** - Visa is buying the AI fraud prevention platform BioCatch in an all-cash deal.
- 3 (01:14) **AstraZeneca and Bristol-Myers Squibb Tie-Up Rumors** - Shares move after reports of merger discussions between the two pharma giants.
- 4 (01:50) **Nissan Reports First Quarterly Net Profit in Two Years** - The Japanese carmaker shows recovery in U.S. and Japan but warns on China.
- 5 (02:28) **Episode Wrap-Up** - Host concludes the roundup and teases the afternoon update.
- 6 Standout Quotes
- 7 "Visa has been increasing its use of AI to fight fraud, spending $13 billion on fraud technology and infrastructure over the past five years." (01:00)
+ Full timestamped outline available in the app
Show Notes
Plus: AstraZeneca and Bristol Myers Squibb shares swing on reports of a potential tie up. And Nissan reports its first quarterly profit in two years. Imani Moise hosts.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
More from this podcast
WSJ Tech News Briefing →